![](/img/cover-not-exists.png)
Daclizumab, a humanised monoclonal antibody to the interleukin 2 receptor (CD25), for the treatment of moderately to severely active ulcerative colitis: a randomised, double blind, placebo controlled, dose ranging trial
Van Assche, G, Sandborn, W J, Feagan, B G, Salzberg, B A, Silvers, D, Monroe, P S, Pandak, W M, Anderson, F H, Valentine, J F, Wild, G E, Geenen, D J, Sprague, R, Targan, S R, Rutgeerts, P, Vexler, V,Volume:
55
Language:
english
Journal:
Gut
DOI:
10.1136/gut.2005.089854
Date:
November, 2006
File:
PDF, 1010 KB
english, 2006